HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Monday 16 March 2015

HEDS 2014 articles...

...all 118 of them, interspersed with six Wordles of their titles:

  1. Measuring and valuing health-related quality of life among children and adolescents in mainland China--a pilot study. Xu F, Chen G, Stevens K, Zhou H, Qi S, Wang Z, Hong X, Chen X, Yang H, Wang C, et al. PLoS One 9(2):e89222 2014
  2. Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values. Krabbe PF, Devlin NJ, Stolk EA, Shah KK, Oppe M, van Hout B, Quik EH, Pickard AS, Xie F. Med Care 52(11):935-943 Nov 2014
  3. Routine echocardiography in the management of stroke and transient ischaemic attack: a systematic review and economic evaluation. Holmes M, Rathbone J, Littlewood C, Rawdin A, Stevenson M, Stevens J, Archer R, Evans P, Wang J. Health Technol Assess 18(16):1-176 Mar 2014
  4. Cost effectiveness of a pragmatic exercise intervention (EXIMS) for people with multiple sclerosis: economic evaluation of a randomised controlled trial. Tosh J, Dixon S, Carter A, Daley A, Petty J, Roalfe A, Sharrack B, Saxton J. Mult Scler 20(8):1123-1130 13 Jan 2014
  5. Pragmatic intervention for increasing self-directed exercise behaviour and improving important health outcomes in people with multiple sclerosis: a randomised controlled trial. Carter A, Daley A, Humphreys L, Snowdon N, Woodroofe N, Petty J, Roalfe A, Tosh J, Sharrack B, Saxton J. Mult Scler 20(8):1112-1122 13 Jan 2014
  6. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Longworth L, Yang Y, Young T, Mulhern B, Hernández Alava M, Mukuria C, Rowen D, Tosh J, Tsuchiya A, Evans P, et al. Health Technol Assess 18(9):1-224 Feb 2014
  7. Health Assessment Questionnaire disability progression in early rheumatoid arthritis: systematic review and analysis of two inception cohorts. Norton S, Fu B, Scott DL, Deighton C, Symmons DP, Wailoo AJ, Tosh J, Lunt M, Davies R, Young A, et al. Semin Arthritis Rheum 44(2):131-144 Oct 2014
  8. Health economic modelling of treatment sequences for rheumatoid arthritis: a systematic review. Tosh J, Stevenson M, Akehurst R. Curr Rheumatol Rep 16(10):447 Oct 2014
  9. Validation of surrogate endpoints in advanced solid tumors: systematic review of statistical methods, results, and implications for policy makers. Ciani O, Davis S, Tappenden P, Garside R, Stein K, Cantrell A, Saad ED, Buyse M, Taylor RS. Int J Technol Assess Health Care 30(3):312-324 Jul 2014
  10. Factors associated with adherence to treatment with isoniazid for the prevention of tuberculosis amongst people living with HIV/AIDS: a systematic review of qualitative data. Makanjuola T, Taddese HB, Booth A. PLoS One 9(2):e87166 2014
  11. Examining the impact of 11 long-standing health conditions on health-related quality of life using the EQ-5D in a general population sample. Wu M, Brazier JE, Kearns B, Relton C, Smith C, Cooper CL. European Journal of Health Economics 1-11 2014
  12. Examining the incremental impact of long-standing health conditions on subjective well-being alongside the EQ-5D. Wu M, Brazier J, Relton C, Cooper C, Smith C, Blackburn J. Health Qual Life Outcomes 12:61 2014
  13. Valuing health at the end of life: An empirical study of public preferences. Shah KK, Tsuchiya A, Wailoo AJ. European Journal of Health Economics 15(4):389-399 2014
  14. Valuing health at the end of life: A stated preference discrete choice experiment. Shah KK, Tsuchiya A, Wailoo AJ. Soc Sci Med 124:48-56 Jan 2015
  15. Prioritising public health guidance topics in the National Institute for Health and Care Excellence using the Analytic Hierarchy Process. Reddy BP, Kelly MP, Thokala P, Walters SJ, Duenas A. Public Health 128(10):896-903 Oct 2014
  16. A randomised controlled trial and cost-effectiveness evaluation of 'booster' interventions to sustain increases in physical activity in middle-aged adults in deprived urban neighbourhoods. Goyder E, Hind D, Breckon J, Dimairo M, Minton J, Everson-Hock E, Read S, Copeland R, Crank H, Horspool K, et al. Health Technol Assess 18(13):1-210 Feb 2014
  17. From KIDSCREEN-10 to CHU9D: creating a unique mapping algorithm for application in economic evaluation. Chen G, Stevens K, Rowen D, Ratcliffe J. Health Qual Life Outcomes 12:134 2014
  18. Disaster management in low- and middle-income countries: scoping review of the evidence base. Lee AC, Booth A, Challen K, Gardois P, Goodacre S. Emerg Med J 31(e1):e78-e83 Oct 2014
  19. Effects of minimum unit pricing for alcohol on different income and socioeconomic groups: a modelling study. Holmes J, Meng Y, Meier PS, Brennan A, Angus C, Campbell-Burton A, Guo Y, Hill-McManus D, Purshouse RC. Lancet 383(9929):1655-1664 10 May 2014
  20. Are policy decisions on surgical procedures informed by robust economic evidence? A systematic review. Ara R, Basarir H, Keetharuth AD, Barbieri M, Weatherly HL, Sculpher MJ, Ahmed H, Brown S. Int J Technol Assess Health Care 1-13 13 Nov 2014
  21. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Jones ML, Paisley S, O'Cathain A, Barkham M, et al. Health Technol Assess. 2014 May;18(34):vii-viii, xiii-xxv, 1-188.
  22. Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for the treatment of osteoporotic vertebral fractures: a systematic review and cost-effectiveness analysis. Stevenson M, Gomersall T, Lloyd Jones M, Rawdin A, Hernández M, Dias S, Wilson D, Rees A. Health Technol Assess 18(17):1-290 Mar 2014
  23. The cost-effectiveness of weight management programmes in a postnatal population. Rawdin AC, Duenas A, Chilcott JB. Public Health 128(9):804-810 Sep 2014
  24. Using logic model methods in systematic review synthesis: describing complex pathways in referral management interventions. Baxter SK, Blank L, Woods HB, Payne N, Rimmer M, Goyder E. BMC Med Res Methodol 14:62 2014
  25. Alcohol tax pass-through across the product and price range: do retailers treat cheap alcohol differently? Ally AK, Meng Y, Chakraborty R, Dobson PW, Seaton JS, Holmes J, Angus C, Guo Y, Hill-McManus D, Brennan A, et al. Addiction 109(12):1994-2002 Dec 2014
  26. What are the Implications for Policy Makers? A Systematic Review of the Cost-Effectiveness of Screening and Brief Interventions for Alcohol Misuse in Primary Care. Angus C, Latimer N, Preston L, Li J, Purshouse R. Front Psychiatry 5:114 2014
  27. Modelling the economics of type 2 diabetes mellitus prevention: a literature review of methods. Watson P, Preston L, Squires H, Chilcott J, Brennan A. Appl Health Econ Health Policy 12(3):239-253 Jun 2014
  28. Valuing trial designs from a pharmaceutical perspective using value-based pricing. Breeze P, Brennan A. Health Econ 09 Sep 2014
  29. An integrated extrapolation of long-term outcomes in systemic lupus erythematosus: analysis and simulation of the Hopkins Lupus Cohort. Watson P, Brennan A, Birch H, Fang H, Petri M. Rheumatology (Oxford) 17 Sep 2014
  30. Comparison of general population, patient, and carer utility values for dementia health States. Rowen D, Mulhern B, Banerjee S, Tait R, Watchurst C, Smith SC, Young TA, Knapp M, Brazier JE. Med Decis Making 35(1):68-80 Jan 2015
  31. Intervention Now to Eliminate Repeat Unintended Pregnancy in Teenagers (INTERUPT): A systematic review of intervention effectiveness and cost-effectiveness, qualitative and realist synthesis of implementation factors and user engagement. Whitaker R, Hendry M, Booth A, Carter B, Charles J, Craine N, Edwards RT, Lyons M, Noyes J, Pasterfield D, et al. BMJ Open 4(4) 2014 DOI
  32. Estimation of own and cross price elasticities of alcohol demand in the UK-A pseudo-panel approach using the Living Costs and Food Survey 2001-2009. Meng Y, Brennan A, Purshouse R, Hill-McManus D, Angus C, Holmes J, Meier PS. J Health Econ 34:96-103 Mar 2014
  33. Cost-effectiveness of a programme of screening and brief interventions for alcohol in primary care in Italy. Angus C, Scafato E, Ghirini S, Torbica A, Ferre F, Struzzo P, Purshouse R, Brennan A. BMC Fam Pract 15:26 2014
  34. The Sheffield Alcohol Policy Model – a mathematical description. Brennan A, Meier P, Purshouse R, Rafia R, Meng Y, Hill-Macmanus D, Angus C, Holmes J. Health Econ 30 Sep 2014
  35. Enhancements to angioplasty for peripheral arterial occlusive disease: systematic review, cost-effectiveness assessment and expected value of information analysis. Simpson EL, Kearns B, Stevenson MD, Cantrell AJ, Littlewood C, Michaels JA. Health Technol Assess 18(10):1-252 Feb 2014
  36. Predicting preference-based utility values using partial proportional odds models. Ara R, Kearns B, vanHout BA, Brazier JE. BMC Res Notes 7:438 2014 Author URL DOI
  37. Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme. Kearns B, Whyte S, Chilcott J, Patnick J. Br J Cancer 111(9):1734-1741 28 Oct 2014
  38. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation. Leaviss J, Sullivan W, Ren S, Everson-Hock E, Stevenson M, Stevens JW, Strong M, Cantrell A. Health Technol Assess 18(33):1-120 May 2014
  39. Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins. Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Cantrell A, Michaels J. Br J Surg 101(9):1040-1052 Aug 2014
  40. Clinical and cost-effectiveness of minimally invasive techniques for the treatment of varicosis: Systematic review and economic evaluation. Leaviss J, Hummel S, Carroll C, Ren S, Stevens JW, Everson-Hock E, Cantrell A, Stevenson M, Michaels J. Vasomed 26(4):210-211 2014
  41. Prehospital noninvasive ventilation for acute respiratory failure: systematic review, network meta-analysis, and individual patient data meta-analysis. Goodacre S, Stevens JW, Pandor A, Poku E, Ren S, Cantrell A, Bounes V, Mas A, Payen D, Petrie D, et al. Acad Emerg Med 21(9):960-970 Sep 2014
  42. Adherence to the nice head injury guidelines 2007 and 2014 in anticoagulated patients. Kuczawski M, Mason S, Stevenson M, Holmes M, Teare MD, Ramlakhan S, Goodacre S, Morris F, Harper R. England. Emerg Med J. 31: 775. Sep 2014
  43. The ahead study: managing anticoagulated patients who suffer head injury. Mason S, Kuczawski M, Teare MD, Stevenson M, Holmes M, Ramlakhan S, Goodacre S, Morris F, Harper R. England. Emerg Med J. 31: 775. Sep 2014
  44. The Cost Effectiveness of Dry Powder Antibiotics for the Treatment of Pseudomonas aeruginosa in Patients with Cystic Fibrosis. Tappenden P, Harnan S, Uttley L, Mildred M, Walshaw M, Taylor C, Brownlee K. PHARMACOECONOMICS 32(2):159-172 Feb 2014 DOI
  45. Dry powder inhalers in cystic fibrosis: same old drugs but different benefits? Uttley L, Tappenden P. Curr Opin Pulm Med 20(6):607-612 Nov 2014
  46. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM. Health Technol Assess 18(59):1-120 Sep 2014
  47. The impact of spatial and temporal availability of alcohol on its consumption and related harms: a critical review in the context of UK licensing policies. Holmes J, Guo Y, Maheswaran R, Nicholls J, Meier PS, Brennan A. Drug Alcohol Rev 33(5):515-525 Sep 2014
  48. Potential benefits of minimum unit pricing for alcohol versus a ban on below cost selling in England 2014: modelling study. Brennan A, Meng Y, Holmes J, Hill-McManus D, Meier PS. BMJ 349:g5452 2014 Author URL Repository public URL
  49. Reporting the characteristics of the policy context for population-level alcohol interventions: a proposed 'Transparent Reporting of Alcohol Intervention ContExts' (TRAICE) checklist. Holmes J, Meier PS, Booth A, Brennan A. Drug Alcohol Rev 33(6):596-603 Nov 2014
  50. Assessing the cost-effectiveness of Type 1 diabetes interventions: The Sheffield Type 1 Diabetes Policy Model. Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J, Heller S. Diabetic Medicine 31(4):477-486 2014
  51. The economics of cardiac biomarker testing in suspected myocardial infarction. Goodacre S, Thokala P. Clin Biochem 27 Aug 2014
  52. Resource Modelling: The Missing Piece of the HTA Jigsaw? Thokala P, Dixon S, Jahn B. Pharmacoeconomics 20 Nov 2014
  53. Preference-based health-related quality of life in the context of aphasia: a research synthesis. Whitehurst DGT, Latimer NR, Kagan A, Palmer R, Simmons-Mackie N, Hoch JS. Aphasiology 08 Dec 2014
  54. The cost-effectiveness of multi-component interventions to prevent delirium in older people undergoing surgical repair of hip fracture. Akunne A, Davis S, Westby M, Young J. European Journal of Orthopaedic Surgery and Traumatology 24(2):187-195 Feb 2014
  55. Alteplase for the Treatment of Acute Ischaemic Stroke: A NICE Single Technology Appraisal; an Evidence Review Group Perspective. Holmes M, Davis S, Simpson E. Pharmacoeconomics 26 Nov 2014
  56. Mapping from the Health Assessment Questionnaire to the EQ-5D: The Impact of Different Algorithms on Cost-Effectiveness Results. Pennington B, Davis S. Value Health 17(8):762-771 Dec 2014
  57. The effectiveness of sexual health interventions for people with severe mental illness: a systematic review. Kaltenthaler E, Pandor A, Wong R. Health Technol Assess 18(1):1-74 Jan 2014
  58. Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisal. Latimer NR, Carroll C, Wong R, Tappenden P, Venning MC, Luqmani R. Pharmacoeconomics 32(12):1171-1183 Dec 2014
  59. Measuring quality of life in mental health: Are we asking the right questions? Connell J, O'Cathain A, Brazier J. Soc Sci Med 120:12-20 Nov 2014
  60. Do EQ-5D and SF-6D ask the right questions in mental health? A content validation using interviews with patients. Brazier JE, Connell J, O'Cathain A. VALUE IN HEALTH 17(3):A194-A194 May 2014
  61. PROMs in Secondary Mental Health Services in the UK: a Feasibility Study and Lessons Learnt. Keetharuth A, Brazier J, Gibbons E, Ricketts T, Khan M, Connell J, Barkham M. JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS 17:S10-S10 Sep 2014
  62. Assessing uncertainties surrounding combined endpoints for use in economic models. Heeg BM, van Hout BA. Med Decis Making 34(3):300-310 Apr 2014
  63. A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol. Oppe M, Devlin NJ, van Hout B, Krabbe PF, de Charro F. Value Health 17(4):445-453 Jun 2014
  64. Interim EQ-5D-5L Value Set for Poland: First Crosswalk Value Set in Central and Eastern Europe. Golicki D, Niewada M, Hout BV, Janssen MF, Pickard AS.
  65. A Comparison of Methods for Converting DCE Values onto the Full Health-Dead QALY Scale. Rowen D, Brazier J, Van Hout B. Med Decis Making 14 Nov 2014
  66. Substantial reductions in the number of diabetic ketoacidosis and severe hypoglycaemia episodes requiring emergency treatment lead to reduced costs after structured education in adults with Type 1 diabetes. Elliott J, Jacques RM, Kruger J, Campbell MJ, Amiel SA, Mansell P, Speight J, Brennan A, Heller SR. Diabet Med 31(7):847-853 Jul 2014
  67. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J. Br J Psychiatry 205(3):236-243 Sep 2014
  68. Identification and review of cost-effectiveness model parameters: a qualitative study. Kaltenthaler E, Essat M, Tappenden P, Paisley S. Int J Technol Assess Health Care 30(3):333-340 Jul 2014
  69. Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study. Whyte S, Harnan S. Cancer Causes Control 25(6):647-658 Jun 2014
  70. The Relative Effectiveness of Pumps Over MDI and Structured Education (REPOSE): study protocol for a cluster randomised controlled trial. White D, Waugh N, Elliott J, Lawton J, Barnard K, Campbell MJ, Dixon S, Heller S, REPOSE group. BMJ Open 4(9):e006204 2014
  71. The cost-effectiveness of a theory-based online health behaviour intervention for new university students: an economic evaluation. Kruger J, Brennan A, Strong M, Thomas C, Norman P, Epton T. BMC Public Health 14:1011 2014
  72. A cluster randomized controlled non-inferiority trial of 5-day Dose Adjustment for Normal Eating (DAFNE) training delivered over 1 week versus 5-day DAFNE training delivered over 5 weeks: the DAFNE 5 × 1-day trial. Elliott J, Rankin D, Jacques RM, Lawton J, Emery CJ, Campbell MJ, Dixon S, Heller SR, the NIHR DAFNE Research Study Group. Diabet Med 01 Nov 2014
  73. Preparatory study for the revaluation of the EQ-5D tariff: methodology report. Mulhern B, Bansback N, Brazier J, Buckingham K, Cairns J, Devlin N, Dolan P, Hole AR, Kavetsos G, Longworth L, et al. Health Technol Assess 18(12):vii-191 Feb 2014
  74. Testing a discrete choice experiment including duration to value health states for large descriptive systems: addressing design and sampling issues. Bansback N, Hole AR, Mulhern B, Tsuchiya A. Soc Sci Med 114:38-48 Aug 2014
  75. Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds. Nicholson KG, Abrams KR, Batham S, Medina MJ, Warren FC, Barer M, Bermingham A, Clark TW, Latimer N, Fraser M, et al. Health Technol Assess 18(36):1-viii May 2014
  76. Health promotion interventions for increasing stroke awareness in ethnic minorities: a systematic review of the literature. Gardois P, Booth A, Goyder E, Ryan T. BMC Public Health 14:409 2014
  77. Adjusting survival time estimates to account for treatment switching in randomized controlled trials--an economic evaluation context: methods, limitations, and recommendations. Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, Akehurst RL, Campbell MJ. Med Decis Making 34(3):387-402 Apr 2014
  78. Adjusting for treatment switching in randomised controlled trials - A simulation study and a simplified two-stage method. Latimer NR, Abrams K, Lambert P, Crowther M, Wailoo A, Morden J, Akehurst R, Campbell M. Stat Methods Med Res 21 Nov 2014
  79. The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma. Goodacre S, Cohen J, Bradburn M, Stevens J, Gray A, Benger J, Coats T, 3Mg Research Team. Health Technol Assess 18(22):1-168 Apr 2014
  80. Developing a utility index for the Aberrant Behavior Checklist (ABC-C) for fragile X syndrome. Kerr C, Breheny K, Lloyd A, Brazier J, Bailey Jr DB, Berry-Kravis E, Cohen J, Petrillo J. Quality of Life Research 26 Jul 2014
  81. Patient and public involvement in scope development for a palliative care health technology assessment in europe. Brereton L, Goyder E, Ingleton C, Gardiner C, Chilcott J, van der Wilt GJ, Oortwijn W, Mozygemba K, Lysdahl KB, Sacchini D, Lepper W. BMJ Support Palliat Care 4 Suppl 1:A40-A41 Mar 2014
  82. Promoting Health Literacy through Community Based Peer Support: a participatory approach to a realist review. Croot L, Harris J, Thompson J, Van Cleemput P, Booth A, Campbell F, Springett J, Wilkins E. INTERNATIONAL JOURNAL OF QUALITATIVE METHODS. 12: 727-728. 2013
  83. A theory-based online health behaviour intervention for new university students (U@Uni): results from a randomised controlled trial. Epton T, Norman P, Dadzie AS, Harris PR, Webb TL, Sheeran P, Julious SA, Ciravegna F, Brennan A, Meier PS, et al. BMC Public Health 14:563 2014
  84. Modelling the relationship between the WOMAC Osteoarthritis Index and EQ-5D. Wailoo A, Hernandez Alava M, Escobar Martinez A. Health Qual Life Outcomes 12:37 2014
  85. Cost-effectiveness of treatment strategies using combination disease-modifying anti-rheumatic drugs and glucocorticoids in early rheumatoid arthritis. Wailoo A, Hernández Alava M, Scott IC, Ibrahim F, Scott DL. Rheumatology (Oxford) 53(10):1773-1777 Oct 2014
  86. Methods for handling uncertainty within pharmaceutical funding decisions. Stevenson M, Tappenden P, Squires H. International Journal of Systems Science 45(1):60-68 01 Jan 2014
  87. Quality of life impact of mental health conditions in England: results from the adult psychiatric morbidity surveys. Roberts J, Lenton P, Keetharuth AD, Brazier J. Health Qual Life Outcomes 12:6 2014
  88. Generalizability and unaddressed issues in mapping: how do we decide when to map? Young TA. Med Decis Making 34(7):824-825 Oct 2014
  89. Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach. Costa DS, Aaronson NK, Fayers PM, Grimison PS, Janda M, Pallant JF, Rowen D, Velikova G, Viney R, Young TA, et al. Patient Relat Outcome Meas 5:119-129 2014
  90. The development of cancer-specific multi-attribute utility instruments from the EORTC QLQ-C30 and FACT-G. Costa DSJ, King MT, Aaronson NK, Brazier JE, Cella D, Fayers PM, Grimison P, Janda M, McTaggart-Cowan H, Norman R, et al. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 10:31-31 Nov 2014
  91. Prevention of retinal detachment in Stickler syndrome: the Cambridge prophylactic cryotherapy protocol. Fincham GS, Pasea L, Carroll C, McNinch AM, Poulson AV, Richards AJ, Scott JD, Snead MP. Ophthalmology 121(8):1588-1597 Aug 2014
  92. Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population. Mulhern B, Rowen D, Snape D, Jacoby A, Marson T, Hughes D, Baker G, Brazier J. Epilepsy Behav 36:12-17 Jul 2014
  93. Patient-reported utilities in advanced or metastatic melanoma, including analysis of utilities by time to death. Hatswell AJ, Pennington B, Pericleous L, Rowen D, Lebmeier M, Lee D. Health Qual Life Outcomes 12(1):140 10 Sep 2014
  94. Do cancer patient distinguish between the importance and severity of their quality of life concerns? Costa D, King M, Aaronson N, Brazier J, Cella D, Grimison P, Janda M, McTaggart-Cowan H, Pickard S, Rowen D, et al. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 10:31-31 Nov 2014
  95. What is the quality of economic evaluations of non-drug therapies? A systematic review and critical appraisal of economic evaluations of radiotherapy for cancer. Barbieri M, Weatherly HL, Ara R, Basarir H, Sculpher M, Adams R, Ahmed H, Coles C, Guerrero-Urbano T, Nutting C, et al. Appl Health Econ Health Policy 12(5):497-510 Oct 2014
  96. The potential of the Child Health Utility 9D Index as an outcome measure for child dental health. Foster Page LA, Thomson WM, Marshman Z, Stevens KJ. BMC Oral Health 14(1) 16 Jul 2014
  97. Update on romiplostim and eltrombopag indirect comparison. Cooper K, Matcham J, Helme K, Akehurst R. Int J Technol Assess Health Care 30(1):129-130 Jan 2014
  98. Distributional cost-effectiveness analysis of health care programmes – a methodological case study of the UK bowel cancer screening programme. Asaria M, Griffin S, Cookson R, Whyte S, Tappenden P. Health Econ 02 May 2014
  99. Avoiding and identifying errors and other threats to the credibility of health economic models. Tappenden P, Chilcott JB. Pharmacoeconomics 32(10):967-979 Oct 2014
  100. Effect of adding a sleep dimension to the EQ-5D descriptive system: a "bolt-on" experiment. Yang Y, Brazier J, Tsuchiya A. Med Decis Making 34(1):42-53 Jan 2014
  101. Egalitarianism and altruism in health: some evidence of their relationship. Abásolo I, Tsuchiya A. Int J Equity Health 13:13 2014
  102. Blood donation as a public good: An empirical investigation of the free rider problem. Abásolo I, Tsuchiya A. European Journal of Health Economics 15(3):313-321 2014
  103. Societal preferences for distributive justice in the allocation of health care resources: a latent class discrete choice experiment. Skedgel C, Wailoo A, Akehurst R. Med Decis Making 35(1):94-105 Jan 2015
  104. Health-related quality-of-life of coal-based sponge iron plant workers in Barjora, India: a cross-sectional study. Chattopadhyay K, Chattopadhyay C, Kaltenthaler E. BMJ Open 4(9):e006047 2014 Author URL DOI
  105. Modelling the cost effectiveness of interventions for osteoporosis: issues to consider. Stevenson MD, Selby PL. Pharmacoeconomics 32(8):735-743 Aug 2014
  106. Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25. Rentz AM, Kowalski JW, Walt JG, Hays RD, Brazier JE, Yu R, Lee P, Bressler N, Revicki DA. JAMA Ophthalmol 132(3):310-318 Mar 2014
  107. A systematic review of calcium channel blocker use and cognitive decline/dementia in the elderly. Peters R, Booth A, Peters J. J Hypertens 32(10):1945-1957 Oct 2014
  108. The random card sort method and respondent certainty in contingent valuation: An exploratory investigation of range bias. Shackley P, Dixon S. Health Economics (United Kingdom) 23(10):1213-1223 2014
  109. Health state utilities for skeletal-related events secondary to bone metastases. Matza LS, Chung K, Van Brunt K, Brazier JE, Braun A, Currie B, Palsgrove A, Davies E, Body JJ. Eur J Health Econ 15(1):7-18 Jan 2014
  110. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises. Whitehurst DG, Norman R, Brazier JE, Viney R. Value Health 17(5):570-577 Jul 2014
  111. A comparison of Hong Kong and United Kingdom SF-6D health states valuations using a nonparametric Bayesian method. Kharroubi SA, Brazier JE, McGhee S. Value Health 17(4):397-405 Jun 2014
  112. Economic evaluation in short bowel syndrome (SBS): an algorithm to estimate utility scores for a patient-reported SBS-specific quality of life scale (SBS-QoL™). Lloyd A, Kerr C, Breheny K, Brazier J, Ortiz A, Borg E. Qual Life Res 23(2):449-458 Mar 2014
  113. An Australian discrete choice experiment to value EQ-5D health states. Viney R, Norman R, Brazier J, Cronin P, King MT, Ratcliffe J, Street D. Health Economics (United Kingdom) 23(6):729-742 2014
  114. Modeling a preference-based index for two condition-specific measures (asthma and overactive bladder) using a nonparametric Bayesian method. Kharroubi SA, Brazier JE, Yang Y. Value Health 17(4):406-415 Jun 2014
  115. Responsiveness was similar between direct and mapped SF-6D in colorectal cancer patients who declined. Wong CKH, Mulhern B, Wan Y-F, Lam CLK. Journal of Clinical Epidemiology 67(2):219-227 Feb 2014
  116. The construct validity and responsiveness of the EQ-5D, SF-6D and Diabetes Health Profile-18 in type 2 diabetes. Mulhern B, Meadows K. Health Qual Life Outcomes 12:42 2014
  117. Endovascular repair of abdominal aortic aneurysm. Paravastu SC, Jayarajasingam R, Cottam R, Palfreyman SJ, Michaels JA, Thomas SM. Cochrane Database Syst Rev 1:CD004178 2014
  118. Response to letter to editor: Capturing disutility from waiting time. Brennan VK, Dixon S. Pharmacoeconomics 32(4):421-422 Apr 2014

Posted by at
Labels: